Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RARB | P10826 | 13/20 | 1.00 |
| ▸ | RARG | P13631 | 12/20 | 1.00 |
| ▸ | RARA | P10276 | 11/20 | 1.00 |
| ▸ | CYP26A1 | O43174 | 4/20 | 1.00 |
| ▸ | CYP26B1 | Q9NR63 | 3/20 | 1.00 |
| ▸ | RXRA | P19793 | 7/20 | 0.80 |
| ▸ | RXRB | P28702 | 6/20 | 0.80 |
| ▸ | RXRG | P48443 | 4/20 | 0.80 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8439958 | 0.92 | RARB (0.86) | RARBRARGRARACYP26A1CYP26B1 | |
| SCHEMBL8523097 | 0.91 | RARB (0.83) | RARBRARGRARACYP26A1CYP26B1 | |
| SCHEMBL10355871 | 0.89 | RXRA (1.00) | RARBRARGRARACYP26A1CYP26B1 | |
| SCHEMBL29827631 | 0.89 | RARB (0.81) | RARBRARGRARACYP26A1CYP26B1 | |
| SCHEMBL846110 | 0.89 | RARB (0.81) | RARBRARGRARACYP26A1CYP26B1 | |
| SCHEMBL9747842 | 0.88 | RARB (1.00) | RARBRARGRARACYP26A1CYP26B1 | |
| SCHEMBL7761329 | 0.88 | RARB (0.80) | RARBRARGRARACYP26A1CYP26B1 | |
| Hydrochloric Acid SCHEMBL9120757 | 0.87 | RARB (0.78) | RARBRARGRARACYP26A1CYP26B1 | |
| SCHEMBL8733241 | 0.87 | RARB (0.83) | RARBRARGRARACYP26A1CYP26B1 | |
| SCHEMBL2331952 | 0.87 | RARB (1.00) | RARBRARGRARACYP26A1CYP26B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 68 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1227791-B1 | USE OF AROMATIC POLYCYCLIC COMPOUNDS AS ACTIVATORS OF PPARS-TYPE RECEPTORS IN A COSMETIC OR PHARMACEUTICAL COMPOSITION | OREAL (FR) | 2006-11-08 | — | — | EP | claimed |
| US-20050208001-A1 | PPAR receptor activator compounds for treating cutaneous disorders/afflictions | SOCIETE L'OREAL, S.A. (FR) | 2005-09-22 | — | — | US | claimed |
| US-6686386-B1 | COMBATING PHOTOINDUCED OR CHRONOLOGICAL AGEING OF SKIN WITH RETENOIC ACID RECEPTOR AGONIST | GALDERMA RESEARCH & DEVELOPMENT S.N.C. (FR) | 2004-02-03 | — | — | US | claimed |
| US-6593359-B1 | Pharmaceutical composition for increasing the rate of apoptosis in at least one cell population in which apoptosis may be induced by activating gamma -RAR receptors is disclosed. | CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIOUES GALDERMA (C.I.R.D. GALDERMA) (FR) | 2003-07-15 | — | — | US | claimed |
| US-20030013734-A1 | PPAR receptor activator compounds for treating cutaneous disorders/afflictions | MAIGNAN JEAN (FR) | 2003-01-16 | — | — | US | claimed |
| US-20020049250-A1 | PPAR receptor activator compounds for treating cutaneous disorders/afflictions | SOCIETE L'OREAL, S.A. (FR) | 2002-04-25 | — | — | US | claimed |
| US-20010018456-A1 | Use of a RAR-gamma-specific agonist ligand for increasing the rate of apoptosis | FESUS LASZLO (HU) | 2001-08-30 | — | — | US | claimed |
| EP-0220118-B1 | BICYCLIC NAPHTHALENIC DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THEIR USE IN HUMAN AND VETERINARY MEDICINE AND COSMETICS | CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES GALDERMA - CIRD GALDERMA (FR) | 1992-01-02 | — | — | EP | claimed |
| CN-122095314-A | Photosensitive resin laminate, method for forming resist pattern, and method for manufacturing wiring board having conductor pattern | — | 2026-05-26 | — | — | CN | disclosed |
| CN-122029490-A | Photosensitive resin laminate, method for forming resist pattern, and method for forming wiring board | 旭化成株式会社 | 2026-05-12 | — | — | CN | disclosed |
| US-12410330-B2 | Energy curable, heat activated flexographic adhesives for die-less foiling | INX INTERNATIONAL INK CO. (US) | 2025-09-09 | — | — | US | disclosed |
| EP-3955900-B1 | POLYMERIC CAPSULES | PROCTER & GAMBLE (US) | 2025-07-23 | — | — | EP | disclosed |
| WO-2025134720-A1 | NON-POLYMER COMPOUND AND COMPOSITION FOR FILM FORMATION | 日産化学株式会社 | 2025-06-26 | — | — | WO | disclosed |
| CN-120077329-A | Photosensitive resin composition, photosensitive resin laminate, and method for forming resist pattern | 旭化成株式会社 | 2025-05-30 | — | — | CN | disclosed |
| WO-1999048529-A1 | RETINOID-GLITAZONE COMBINATIONS | WARNER-LAMBERT COMPANY (US) | 1999-09-30 | — | — | WO | disclosed |
| EP-0808159-A1 | USE OR RETINOIDS TO LOWER PLASMA LEVELS OF LIPOPROTEIN (a) | WARNER-LAMBERT COMPANY (US) | 1997-11-26 | — | — | EP | disclosed |
| WO-1996024344-A1 | USE OF RETINOIDS TO LOWER PLASMA LEVELS OF LIPOPROTEIN (a) | WARNER-LAMBERT COMPANY (US) | 1996-08-15 | — | — | WO | disclosed |
| US-5489611-A | ADMINISTERING A RETINOID COMPOUND | WARNER-LAMBERT COMPANY (US) | 1996-02-06 | — | — | US | disclosed |
| US-5004732-A | Treatment of acne | SOCIETE ANONYME DITE: L'OREAL (FR) | 1991-04-02 | — | — | US | disclosed |
| US-4826969-A | SKIN AND EYE DISORDERS | CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES C.I.R.D. (FR) | 1989-05-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020049250-A1 | PPAR receptor activator compounds for treating cutaneous disorders/afflictions | PPARG, PPARA, PPARD | RARB 20/4885RARG 28/4885RARA 12/4885 |
| US-20030013734-A1 | PPAR receptor activator compounds for treating cutaneous disorders/afflictions | PPARG, PPARA, PPARD | RARB 20/4885RARG 28/4885RARA 12/4885 |
| US-20050208001-A1 | PPAR receptor activator compounds for treating cutaneous disorders/afflictions | PPARG, PPARA, PPARD | RARB 23/4885RARG 28/4885RARA 12/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.